Showing search results for `Cell Therapies`.
News [Showing 8 results of 8 found]:
- Charles River Aquires Hemacare
- Latest Microbiology Newsletter - 10 Dec 2019
- Rapid Microbiological Methods for ATMPs/Gene and Cell Therapies
- The Fastest Way to Expand Biotherapeutic Production Capacity
- Testing Biotherapeutics for Mycoplasmas - the Risks and International Regulations
- Managing Microbial Contamination Risk in ATMPs Manufacture
- A New Automation Solution for the Production and Delivery of Cell and Gene Therapy
- Modular Manufacturing Solution Speeds Access to Novel Biotherapeutics
Supplier [Showing 3 results of 3 found]:
Featured Products:[Showing 1 results of 1 found]:
Get our eNewsletter
Get the latest microbiology news every week - straight to your inbox!
LATEST MICROBIOLOGY NEWS
- Detect Salmonella in Food and Environmental Samples Within 24 Hours
- One Stop Shop for Quick, Reliable Endotoxin and Beta-Glucan Testing
- New CE-Marked COVID-19 Antibody Test Delivers Results in One Minute
- FDA Authorizes Point-of-Care Rapid Antigen Test for COVID-19 & Influenza A/B
- How to Reduce Plastic Waste in a Microbiology Laboratory
- Join Bio-Rad on our Virtual Booth at IAFP
- Short Talk: MAS-100 NT | Validation of the HEPA Filter
- Short Webinar: Key Challenges When Selecting Media for Media Fill Tests
- One Protocol for the Detection of Campylobacter & Salmonella in Poultry
- instaBAG Fraser ½ Makes Selective Enrichment of Listeria Easier
MICROBIOLOGY EVENTS
- Webinar Series: Quality Assurance for Quantitative Microbiological Test Methods
- The Effect of β-Glucans on LAL Activity in Pre-treatment Water
- Pharmig's Adriatic Virtual Conference - Hot Topics in Pharmaceutical Production and Microbiology
- COVID-19 Prevention Measures,& Best Practices for Cleaning and Sterility Testing - Webinar Series
- Statistics for Quality Control
- 2020 PDA Rapid Microbiological Methods Workshop: Now Virtual
- Laboratory Inspection and Auditing
- IAFP 2020 A Virtual Annual Meeting
- Pharmaceutical Microbiology East Coast Virtual Conference
- Exclusion of Objectionable Microorganisms from Pharmaceutical and OTC Drug Products